Excellence in Hemoglobinopathies Research Award Program

by: Michael Saunders

The National Institutes of Health, more commonly known as the NIH, is a federal government agency operating within the United States Department of Health and Human Services that is appropriately responsible for supporting the nation's biomedical and health-related research studies.

The programs and grants of the NIH are specifically tailored to help in the achievement of its general agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a collaboration with the National Heart, Lung, and Blood Institute (NHLBI) in an effort to establish the Excellence in Hemoglobinopathies Research Award Program wherein both agencies have agreed to financially support the creation of studies that could potentially improve high-impact multi-disciplinary basic and translational research studies in the hemoglobinopathies.

Initially, the NIH and the NHLBI will enter into a five-year cooperative agreement with the most compelling applicant who has submitted a research proposal that could potentially develop therapeutic molecules, biomarkers, or imaging modalities in the field of hemoglobinopathies.

  (continued...)

Excellence in Hemoglobinopathies Research Award Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on artist grants and children grants.

Additional Resources

category - Health Grants

OMICS Technologies For Predictive Modeling of Infectious Diseases Program
In keeping with this mission, the National Institutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the OMICS Technologies For Predictive Modeling of Infectious Diseases Program.

---

HIV Innovations for Improved Patient Outcomes for Priority Populations Program
The United States Agency for International Development in South Africa has recently established the HIV Innovations for Improved Patient Outcomes for Priority Populations Program wherein it intends to solicit applications coming from local organizations which are interested in heading the implementation of a five-year plan centered on the program in focus.

---

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award Program
The National Institutes of Health has recently form a partnership with the National Cancer Institute in an effort to establish the Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award Program.

---